2012 EORTC: SGI-110 enhances sorafenib activity and alters methylation signature of HCC Cell lines

2012 EORTC: SGI-110 enhances sorafenib activity and alters methylation signature of HCC Cell lines

2012 AACR: Chemosensitizing effects of DNA methylation inhibitor SGI-110 in Ovarian Cancer

2012 AACR: Chemosensitizing effects of DNA methylation inhibitor SGI-110 in Ovarian Cancer

2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110

2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110